Novo Nordisk (NVO)
(Delayed Data from NYSE)
$126.85 USD
+1.06 (0.84%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $126.90 +0.05 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/2/24 |
---|---|
Current Quarter | 0.77 |
EPS Last Quarter | 0.71 |
Last EPS Surprise | 7.58% |
ABR | 1.54 |
Earnings ESP
|
-1.30% |
---|---|
Current Year | 3.32 |
Next Year | 4.09 |
EPS (TTM) | 2.70 |
P/E (F1) | 38.25 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 9.23B | 9.93B | 41.59B | 51.55B |
# of Estimates | 1 | 1 | 2 | 3 |
High Estimate | 9.23B | 9.93B | 42.21B | 52.46B |
Low Estimate | 9.23B | 9.93B | 40.96B | 50.71B |
Year ago Sales | 7.69B | 7.93B | 33.71B | 41.59B |
Year over Year Growth Est. | 19.93% | 25.12% | 23.36% | 23.95% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.77 | 0.82 | 3.32 | 4.09 |
# of Estimates | 3 | 1 | 6 | 5 |
Most Recent Consensus | NA | NA | 3.21 | NA |
High Estimate | 0.79 | 0.82 | 3.52 | 4.39 |
Low Estimate | 0.74 | 0.82 | 3.18 | 3.56 |
Year ago EPS | 0.64 | 0.63 | 2.70 | 3.32 |
Year over Year Growth Est. | 20.31% | 30.16% | 22.96% | 23.29% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 2 | 2 |
Down Last 60 Days | 1 | 0 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.77 | 0.82 | 3.32 | 4.09 |
7 Days Ago | 0.77 | 0.82 | 3.32 | 4.09 |
30 Days Ago | 0.79 | NA | 3.35 | 4.13 |
60 Days Ago | 0.78 | NA | 3.32 | 4.11 |
90 Days Ago | NA | NA | 3.32 | 4.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.76 | 0.82 | 3.38 | 4.26 |
Zacks Consensus Estimate | 0.77 | 0.82 | 3.32 | 4.09 |
Earnings ESP | -1.30% | 0.00% | 1.83% | 4.08% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.71 | 0.73 | 0.63 | 0.64 | NA |
Estimate | 0.66 | 0.69 | 0.67 | 0.64 | NA |
Difference | 0.05 | 0.04 | -0.04 | 0.00 | 0.01 |
Surprise | 7.58% | 5.80% | -5.97% | 0.00% | 1.85% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more